Trans Urethral Laser Ablation of Recurring Bladder Tumors The real ambulatory care Quick, safe and easy TULA® outpatient procedure with DUAL wavelength Excellent vaporization and hemostasis Management of high-risk patients

TULA® DUAL ‒ DUAL Laser Technology Staying true to its tradition in pioneering new minimally invasive treatments, biolitec® combines DUAL wavelengths of 980 nm / 1470 nm to provide excellent and efficient intra and post-operative results. Dual diode lasers with high quality fiber optics make procedures safe and cost effective for both healthcare professionals and patients. Literature TULA® DUAL Introduction and Objectives: Non-invasive bladder cancer is often recurrent. 5 – 10 % of patients will have recurrences that are small and few. Treating these recurrences causes morbidity to patients because...

Non muscle invasive bladder tumors Non-muscle invasive bladder tumor normally has a high recurrence rate, leading to multiple treatments. Elderly patients with multiple morbidities are not fit for conventional treatment under general anesthesia. TULA® DUAL offers a technique using flexible cystoscopy for the treatment of bladder tumor under local or even no anesthesia in outpatient settings. Advantages: Avoidance of the obturator-nerve reflex Specially designed fibers for best results Controlled and focussed penetration depth with  less thermal spread Atraumatic fiber tip enables a smooth insertion...

to learn more about a whole new world of minimally invasive laser therapies Venous diseases Hemorrhoids and fistulas Wide spectrum of ENT diseases BPH and urological tumors Uterine tumors Cervical and lumbar disc herniation Lung metastases and bronchial tumors biolitec AG Vienna, Austria phone: +43 1 3619 909 50 [email protected] www.biolitec.com biolitec biomedical technology GmbH Jena, Germany Phone: +49 3641 519 53 0 biolitec Schweiz GmbH Wollerau, Switzerland Phone: +41 55 555 30 20 biolitec Italia SRL Milano, Italy Phone: +39 02 8423 0633 biolitec T. C. S. V. P. Ltd. Istanbul, Turkey Phone:...